West Pharmaceutical Services Inc (WST)

157.93 +0.34  +0.22% NYSE Jan 21, 12:21 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/14/2020 09:00 EST Misc West Pharmaceutical Services Inc Fourth Quarter Earnings Conference Call in 2019
02/14/2020 Earnings West Pharmaceutical Services Inc Fourth Quarter Earnings in 2019 Release
01/21/2020 Dividends Amount: 0.16, Declared Date: Dec 13 2019, Pay Date: Feb 05 2020
10/24/2019 09:00 EDT Misc West Pharmaceutical Services Inc Third Quarter Earnings Conference Call for 2019
10/24/2019 Earnings West Pharmaceutical Services Inc Third Quarter Earnings in 2019 Release
10/22/2019 Dividends Amount: 0.16, Declared Date: Jul 25 2019, Pay Date: Nov 06 2019
07/25/2019 09:00 EDT Misc West Pharmaceutical Services Inc Second Quarter Earnings Conference Call in 2019
07/25/2019 Earnings West Pharmaceutical Services Inc Second Quarter Earnings in 2019 Release
07/23/2019 Dividends Amount: 0.15, Declared Date: May 08 2019, Pay Date: Aug 07 2019
05/07/2019 Misc West Pharmaceutical Services Inc Annual General Meeting in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.westpharma.com
  • Investor Relations URL: http://www.westpharma.com/en/Investors/Pages/default.aspx
  • HQ State/Province: Pennsylvania
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Feb. 14, 2020
  • Last Earnings Release: Oct. 24, 2019
  • Next Ex-Dividend Date: Jan. 21, 2020
  • Last Ex-Dividend Date: Jan. 21, 2020
  • Description: West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (76% of 2018 sales) and contract-manufactured products (24%). The firm generates 56% of its revenue from international markets and 44% from the United States.

Top Fund Holders

Symbol Name Weighting
BMRRX BlackRock Mid-Cap Growth Equity R 2.27%
NBGAX Neuberger Berman Genesis Adv 2.26%
FRDRX Franklin Rising Dividends R 2.09%
PDP Invesco DWA Momentum ETF 2.07%
PRJIX T. Rowe Price New Horizons I 1.74%
IJK iShares S&P Mid-Cap 400 Growth ETF 1.20%
VISGX Vanguard Small Cap Growth Index Inv 0.63%
VBK Vanguard Small-Cap Growth ETF 0.63%
IJH iShares Core S&P Mid-Cap ETF 0.63%
MDY SPDR® S&P MIDCAP 400 ETF Trust 0.61%
NAESX Vanguard Small Cap Index Inv 0.28%
VB Vanguard Small-Cap ETF 0.28%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.